While most people with COVID-19 get better within two to three weeks, it has become
clear that a number experience lingering symptoms. The condition is known as
“post-acute COVID-19 syndrome” or “long COVID,” referring to issues that manifest more than
four weeks after patients have recovered from their initial diagnosis.
While COVID-19 has dominated public awareness over the past year and a half,
climate change, pollution, invasive species, fire and more continue to threaten
the world’s future. Fortunately, a group of graduate students could carry out
critical environmental investigations despite pandemic protocols limiting much
scientific activity at UCI in 2020.
Stephanie Hachey, Ph.D., was recently selected as the second-place winner of the 11th Annual Nikon Small World in Motion Competition. A postdoctoral scholar with Molecular Biology and Biochemistry Professor Christopher Hughes, Dr. Hachey submitted a 10-day time-lapse...
For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he’s one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal mutation of the virus, called the delta variant, sparks another wave of cases, he offers his expertise about this threat.
Molecule that changes the shape of mitochondria corrects obesity A team of University of California, Irvine, scientists have discovered a novel pharmacological approach to attenuate the mitochondrial dysfunction that drives diet-induced obesity. The results of their...
he UCI Center for the Neurobiology of Learning and Memory has been awarded a UC-HBCU Initiative Summer Research and Graduate Admissions Pathways Grant from the UC Office of the President to sponsor a partnership with Delaware State University, one of 107 Historically Black Colleges and Universities in the U.S.
Eric Hanse, Ph.D., Sarah Kark, Ph.D., and Giedre Milinkeviciute, Ph.D., are the recipients of this spring’s Dean’s Early Career Research Excellence Award. These awards were created to acknowledge the contributions of outstanding junior investigators whose research is...
The UCI team decided to take a new approach by developing a mouse model better positioned to analyze the causes of late-onset AD. Also called “sporadic AD,” this new model encompasses the remaining 95 percent of cases.
The School of Biological Sciences would like to announce that Christopher C.W. Hughes, professor of Molecular Biology & Biochemistry and Biomedical Engineering, has been awarded the title of UCI Chancellor’s Professor. The Chancellor’s title is designated for...